A few days ago.Nanjing Zhengda Tianqing Pharmaceutical Company Limited (hereinafter referred to as "Nanjing Zhengda Tianqing")s intelligent production workshop, a batch of newly launched medicines are passing through the conveyor belt and entering the packaging process in an orderly manner. A few days later, they will be sent to the laboratory for quality testing, and then after about 20 days of static storage, they will finally be sent to all parts of the country.
The Birth of a Pill
Being redefined
In this nearly 3,000 square meter workshop, more than 20 sets of production equipment are neatly arranged and running efficiently.The raw and auxiliary materials are weighed, granulated, pressed, coated and other processes, and then turned into tablets for the treatment of cardiovascular and cerebrovascular diseases. In the whole workshop, there are only 20 staff members in a single shift.
"Among them, technicians accounted for 80%," said Zhu Wenhua, production technology director of Nanjing Zhengda Tianqing, pointing to the real-time jumping parameters on the operating screen.Granulation is the core process of pharmaceutical production, and nowadays the whole process has been automated and controlled.The staff's main task is to keep an eye on the data on the screen to ensure that each process is accurate.
How many tablets can this workshop produce in a day? The answer is: 15 million tablets!"Another 20% of growth is expected this year."Zhu Wenhua explained that last year, this one workshop alone produced 3.2 billion tablets covering four products.
The increase is not only in production volume, but also in production efficiency and quality assurance capability.
"Drug production must ensure quality, all intelligent can be greater to ensure the safety and effectiveness of drugs." Zhu Wenhua said.Every aspect of the company's drug production has been automated, and an energy management system and a quality trend analysis system have been deployed in the workshop, allowing for full life-cycle monitoring of drugs."In the event of an abnormality, the system will immediately and automatically warn you, and there is a complete monitoring system from the production process to entering the market."
As a national green factory and intelligent factory in Jiangsu Province, Nanjing Zhengda Tianqing has long been not a pharmaceutical enterprise in the traditional sense. Here, intelligence is not the embellishment, but the base color.
The company has 2 preparation production bases, 4 production workshops, 8 pharmaceutical dosage forms and 12 production lines, which can realize an annual output of 6 billion tablets/capsules of oral preparations. The production quality system team of more than 500 people, technical personnel accounted for 86%, and the qualified rate of all varieties of market sampling for many years is 100%.
Behind this intelligent factory is the young team of Nanjing Zhengda Tianqing of nearly 4,000 people - the average age of 33.7 years old, undergraduate education and above accounted for 58%, of which nearly 400 people in the scientific research team, more than 70% postgraduate education and above. The company adheres to the innovative R&D strategy of "generic-led innovation and combination of generic and innovation", with annual R&D investment of 8%-10%, more than twice the industry average; 5-8 high-quality generic drugs are declared and approved every year, and 2 innovative drugs have entered into phase III clinical trials at present. At present, 2 innovative drugs have entered phase III clinical trials and more than 10 innovative drugs are in different stages of development.
In the workshop, the production of tablets is accelerating; on the regional map, the industrial layout is also accelerating.
This year, Qixia District clearly will be biomedicine as one of the advantages of the focus on the track.Aiming at the two major directions of chemical drugs and proprietary Chinese medicines, guiding enterprises such as Nanjing Zhengda Tianqing, Meinovation, Novozymes and so on to increase the research and development of innovative medicines, and making the modularized carriers such as Xingang Biomedical Headquarter Base and Longtan Medical Devices Industrial Park stronger, so as to build the high-end pharmaceutical manufacturing agglomeration area with all our strengths.
At the same time, Qixia District is restructuring the service ecology with reform thinking.The District Enterprise Comprehensive Service Center has been materialized and operated intelligently, and has become the "total port" and "total hub" for enterprise services. The whole chain of "collection - distribution - processing - feedback - evaluation" is closed; the "resource supermarket" built by the government departments is linked with financial institutions to accurately match financing, scenarios, technology and other elements. The "resource supermarket" set up by government departments links up financial institutions to accurately dock financing, scenarios, technology and other elemental needs; enterprise-friendly policies are "free of application and enjoyable" and can be directly accessed for quick enjoyment, so that enterprises can put more energy into development.
The Journey of a Pill
Reflecting the "acceleration" of a city.
From the intelligent workshop running at full capacity
to the accelerated formation of industrial clusters
To the continuous optimization of the business environment
"The beginning of the year is the beginning of the work, the beginning of the work to do" sense of urgency
It is being transformed into real development momentum in Nanjing.
